Julie Legault recently designed a desktop-sized biolab that makes genetic engineering more accessible to consumers. Bioengineering is a rapidly growing industry and this kit allows consumers to experiment with the technology in the comfort of their own home.
Amino is a personal biolab that can be used to grow cells and make new items such as flavors, fragrances and even medicine. The user-friendly system provides instructions from growing living cells and then collecting data in real time. The kit itself contains everything needed to carry out synthetic biology experiments at home, including bacteria, sensors and tools. The idea behind the kit is to help consumers experiment with personalized manufacturing and gain a basic understanding of how the technology is used to make everyday products.
Amino ultimately makes genetic engineering more accessible for consumers.
Personal Desktop Biolabs
This Device Makes Genetic Engineering More Accessible to Consumers
Trend Themes
1. Personalized Manufacturing - Amino allows consumers to experiment with personalized manufacturing, opening up opportunities for customized products.
2. Rapid Growth in Bioengineering - The Amino kit taps into the rapidly growing bioengineering industry, offering consumers a chance to participate in this innovative field.
3. Consumer Accessible Genetic Engineering - The Amino biolab revolutionizes genetic engineering by making it accessible to consumers, empowering them to explore this cutting-edge technology.
Industry Implications
1. Synthetic Biology - Amino's kit allows consumers to carry out synthetic biology experiments at home, opening up the potential for disruptive innovations in this field.
2. Flavors and Fragrances - With Amino, consumers can experiment with growing cells to create new flavors and fragrances, presenting disruptive innovation opportunities in the flavors and fragrances industry.
3. Pharmaceutical - Amino's user-friendly system allows consumers to experiment with genetic engineering to create medicine at home, revealing disruptive potential in the pharmaceutical industry.